
Faculty, Staff and Student Publications
Publication Date
12-12-2023
Journal
Microbiology Spectrum
Abstract
Previous studies have suggested that oral lactoferrin enhances diversity in the gut microbiota in infants while inhibiting the growth of opportunistic pathogens. However, the effect of lactoferrin on infant gut microbiota over time has yet to be thoroughly studied. Our study suggests that lactoferrin oral treatment in infants aged 12-18 months does not affect gut microbiome diversity and composition over time. to our knowledge, this is the first study to report the effect of lactoferrin on infant gut microbiome composition over time and helps elucidate its impact on infant health and its therapeutic potential.
Keywords
Infant, Humans, Gastrointestinal Microbiome, Lactoferrin, Peru, Feces, Administration, Oral, RNA, Ribosomal, 16S
DOI
10.1128/spectrum.00096-23
PMID
37882571
PMCID
PMC10715004
PubMedCentral® Posted Date
December 2023
PubMedCentral® Full Text Version
Post-print
Comments
Associated Data